OPINION
MURRAY M. SCHWARTZ, Senior District Judge.
I. Introduction
Schering Corporation ("Schering") and Biogen, Inc. ("Biogen") (collectively "Schering") filed a patent infringement suit against Amgen, Inc. ("Amgen"), alleging Amgen infringed Biogen's U.S. Patent No. 4,530,901 ("the '901 Patent"), entitled "Recombinant DNA Molecules and Their Use in Producing Human Interferon-Like Polypeptides."
Let's get started

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.
- Updated daily.
- Uncompromising quality.
- Complete, Accurate, Current.